Probi Future Growth
Future criteria checks 4/6
Probi is forecast to grow earnings and revenue by 20.5% and 5.5% per annum respectively while EPS is expected to grow by 20.6% per annum.
Key information
20.5%
Earnings growth rate
20.6%
EPS growth rate
Biotechs earnings growth | 19.3% |
Revenue growth rate | 5.5% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 29 Jan 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 728 | 87 | 137 | 174 | 1 |
12/31/2024 | 684 | 75 | 124 | 162 | 1 |
12/31/2023 | 647 | 73 | 133 | 159 | 1 |
12/31/2022 | 618 | 41 | 91 | 156 | N/A |
9/30/2022 | 644 | 73 | 142 | 203 | N/A |
6/30/2022 | 658 | 79 | 77 | 132 | N/A |
3/31/2022 | 642 | 75 | 104 | 155 | N/A |
12/31/2021 | 658 | 83 | 112 | 154 | N/A |
9/30/2021 | 673 | 79 | 129 | 169 | N/A |
6/30/2021 | 709 | 93 | 164 | 207 | N/A |
3/31/2021 | 731 | 105 | 105 | 149 | N/A |
12/31/2020 | 717 | 93 | 100 | 143 | N/A |
9/30/2020 | 699 | 97 | 57 | 97 | N/A |
6/30/2020 | 645 | 85 | 87 | 132 | N/A |
3/31/2020 | 646 | 88 | 132 | 170 | N/A |
12/31/2019 | 626 | 86 | 138 | 174 | N/A |
9/30/2019 | 623 | 84 | 136 | 164 | N/A |
6/30/2019 | 650 | 90 | 128 | 143 | N/A |
3/31/2019 | 623 | 81 | 140 | 154 | N/A |
12/31/2018 | 604 | 76 | 114 | 128 | N/A |
9/30/2018 | 561 | 53 | 103 | 120 | N/A |
6/30/2018 | 525 | 34 | 77 | 98 | N/A |
3/31/2018 | 544 | 29 | 75 | 100 | N/A |
12/31/2017 | 612 | 69 | 119 | 146 | N/A |
9/30/2017 | 687 | 98 | 140 | 166 | N/A |
6/30/2017 | 643 | 117 | 114 | 136 | N/A |
3/31/2017 | 544 | 118 | 110 | 127 | N/A |
12/31/2016 | 443 | 102 | 71 | 90 | N/A |
9/30/2016 | 286 | 74 | N/A | 52 | N/A |
6/30/2016 | 248 | 60 | N/A | 74 | N/A |
3/31/2016 | 234 | 54 | N/A | 52 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0GZB's forecast earnings growth (20.5% per year) is above the savings rate (1.2%).
Earnings vs Market: 0GZB's earnings (20.5% per year) are forecast to grow faster than the UK market (10.4% per year).
High Growth Earnings: 0GZB's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 0GZB's revenue (5.5% per year) is forecast to grow faster than the UK market (4% per year).
High Growth Revenue: 0GZB's revenue (5.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0GZB's Return on Equity is forecast to be high in 3 years time